No abstract available
MeSH terms
-
Biotechnology* / economics
-
Clinical Trials, Phase II as Topic
-
Commerce / economics
-
Complementary Therapies
-
Cost Savings
-
Dietary Supplements* / economics
-
Dietary Supplements* / standards
-
Drug Approval
-
Drug Industry* / economics
-
Food Labeling / legislation & jurisprudence
-
Food, Organic* / economics
-
Health Care Sector*
-
Humans
-
Japan
-
Managed Care Programs
-
Nutritional Physiological Phenomena
-
Recombinant Proteins / therapeutic use
-
United States
-
United States Food and Drug Administration